Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Tibet Rhodiola Pharmaceutical.

    Client Virtual Booth

    TIBET RHODIOLA PHARMACEUTICAL

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Tibet Rhodiola Pharmaceutical
    China Flag
    Country
    Country
    China
    Address
    Address
    No. 93, Beijing Middle Road, Lhasa, Tibet, Post Code: 850000
    Telephone
    Telephone
    0891-6764272
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xzyy.cn/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Stemirna COVID-19 Vaccine Candidate Obtains Clinical Trial Approval in China

    Details:

    The potential vaccine, which Stemirna has started working on since January last year, is based on messenger RNA (mRNA) technology, Tibet Rhodiola Pharma, which is jointly developing the candidate with Stemirna.


    Lead Product(s): mRNA Covid-19 vaccine

    Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

    Highest Development Status: IND EnablingProduct Type: Vaccine

    Recipient: Stemirna Therapeutics

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable January 05, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    China's Rhodiola Set to Sell and Test Russia's Sputnik-V Vaccine

    Details:

    Tibet Rhodiola Pharmaceutical plans to conduct early and mid-stage trials of the Sputnik V vaccine in China and final-stage trials overseas, although the trials are yet to be approved by regulators.


    Lead Product(s): Gam-COVID-Vac

    Therapeutic Area: Infections and Infectious Diseases Product Name: Sputnik V

    Highest Development Status: Phase IIIProduct Type: Vaccine

    Partner/Sponsor/Collaborator: Undisclosed

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement November 11, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search